OBJECTIVE: To perform a first meta-analysis on the association between female gender and cancer-specific death risk after radical cystectomy. MATERIALS AND METHODS: A comprehensive literature search of the MEDLINE and EMBASE databases was conducted for relevant studies published till November 11, 2014. The meta-analysis was performed by estimating the hazard ratios (HRs) and confidence intervals (CIs) through a random-effect approach. RESULTS: A total of 17 studies were included in the meta-analysis with a total population of 27,912 patients. Female gender was associated with a worse survival outcome (pooled HR 1.20; 95 % CI 1.09-1.32) compared with male gender after radical cystectomy. Subgroup analysis found the correlation was significant in North American and European studies (HR 1.17, 95 % CI 1.02-1.32 and HR 1.34, 95 % CI 1.19-1.51, respectively) and studies from larger size of samples (HR 1.24, 95 % CI 1.11-1.38). We also found studies adjusted for the key elements (T stage, N stage and grade) obtained positive correlation (HR 1.21, 95 % CI 1.09-1.35). CONCLUSIONS: Female demonstrated worse survival outcomes than male after radical cystectomy for bladder cancer. The adoption of more intense cares for female patients was suggested after radical cystectomy.
OBJECTIVE: To perform a first meta-analysis on the association between female gender and cancer-specific death risk after radical cystectomy. MATERIALS AND METHODS: A comprehensive literature search of the MEDLINE and EMBASE databases was conducted for relevant studies published till November 11, 2014. The meta-analysis was performed by estimating the hazard ratios (HRs) and confidence intervals (CIs) through a random-effect approach. RESULTS: A total of 17 studies were included in the meta-analysis with a total population of 27,912 patients. Female gender was associated with a worse survival outcome (pooled HR 1.20; 95 % CI 1.09-1.32) compared with male gender after radical cystectomy. Subgroup analysis found the correlation was significant in North American and European studies (HR 1.17, 95 % CI 1.02-1.32 and HR 1.34, 95 % CI 1.19-1.51, respectively) and studies from larger size of samples (HR 1.24, 95 % CI 1.11-1.38). We also found studies adjusted for the key elements (T stage, N stage and grade) obtained positive correlation (HR 1.21, 95 % CI 1.09-1.35). CONCLUSIONS: Female demonstrated worse survival outcomes than male after radical cystectomy for bladder cancer. The adoption of more intense cares for female patients was suggested after radical cystectomy.
Authors: Matthias May; Maximilian Burger; Sabine Brookman-May; Christian G Stief; Hans-Martin Fritsche; Jan Roigas; Mario Zacharias; Markus Bader; Philipp Mandel; Christian Gilfrich; Michael Seitz; Derya Tilki Journal: Clin Genitourin Cancer Date: 2013-11-13 Impact factor: 2.872
Authors: Marco Moschini; Nazareno Suardi; Federico Pellucchi; Lorenzo Rocchini; Giovanni La Croce; Umberto Capitanio; Alberto Briganti; Rocco Damiano; Francesco Montorsi; Renzo Colombo Journal: Anticancer Res Date: 2014-06 Impact factor: 2.480
Authors: Maximilian Burger; James W F Catto; Guido Dalbagni; H Barton Grossman; Harry Herr; Pierre Karakiewicz; Wassim Kassouf; Lambertus A Kiemeney; Carlo La Vecchia; Shahrokh Shariat; Yair Lotan Journal: Eur Urol Date: 2012-07-25 Impact factor: 20.096
Authors: Surendra B Kolla; Amlesh Seth; Manoj K Singh; Narmada P Gupta; Ashok K Hemal; Prem N Dogra; Rajeev Kumar Journal: Int Urol Nephrol Date: 2008 Impact factor: 2.370
Authors: Alan M Nieder; Yair Lotan; Geoffrey R Nuss; Joshua P Langston; Sachin Vyas; Murugesan Manoharan; Mark S Soloway Journal: Urol Oncol Date: 2008-12-20 Impact factor: 3.498
Authors: Taekmin Kwon; In Gab Jeong; Dalsan You; Bumsik Hong; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim Journal: J Korean Med Sci Date: 2014-04-25 Impact factor: 2.153
Authors: Meera R Chappidi; Max Kates; Hiten D Patel; Jeffrey J Tosoian; Deborah R Kaye; Nikolai A Sopko; Danny Lascano; Jen-Jane Liu; James McKiernan; Trinity J Bivalacqua Journal: Urol Oncol Date: 2016-02-15 Impact factor: 3.498